Industry
Medical - Devices
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Loading...
Open
256.90
Mkt cap
19B
Volume
1.5M
High
275.52
P/E Ratio
45.58
52-wk high
275.52
Low
254.44
Div yield
N/A
52-wk low
152.04
Portfolio Pulse from Benzinga Newsdesk
July 23, 2024 | 11:29 am
Portfolio Pulse from Benzinga Insights
July 19, 2024 | 8:00 pm
Portfolio Pulse from Benzinga Newsdesk
June 24, 2024 | 6:56 am
Portfolio Pulse from Benzinga Insights
June 21, 2024 | 7:00 pm
Portfolio Pulse from Benzinga Newsdesk
June 20, 2024 | 10:07 am
Portfolio Pulse from Benzinga Newsdesk
June 20, 2024 | 10:06 am
Portfolio Pulse from Benzinga Newsdesk
June 10, 2024 | 5:42 pm
Portfolio Pulse from Benzinga Insights
May 30, 2024 | 12:00 pm
Portfolio Pulse from Benzinga Newsdesk
May 30, 2024 | 10:11 am
Portfolio Pulse from Lekha Gupta
May 19, 2024 | 11:27 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.